Prevalence of Therapeutic Drug Monitoring for Lithium and the Impact of Regulatory Warnings: Analysis Using Japanese Claims Database

BACKGROUND: Therapeutic drug monitoring (TDM) for lithium is recommended in guidelines; however, the prevalence of TDM for lithium is seldom reported. We have therefore investigated the prevalence of TDM for lithium and evaluated the impact of the regulatory warnings requiring routine TDM for lithiu...

Descripción completa

Detalles Bibliográficos
Autores principales: Ooba, Nobuhiro, Tsutsumi, Daisuke, Kobayashi, Naoko, Hidaka, Shinji, Hayashi, Hiroyuki, Obara, Taku, Satoh, Michihiro, Kubota, Kiyoshi, Fukuoka, Noriyasu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Therapeutic Drug Monitoring 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865493/
https://www.ncbi.nlm.nih.gov/pubmed/29420333
http://dx.doi.org/10.1097/FTD.0000000000000483

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865493/
https://www.ncbi.nlm.nih.gov/pubmed/29420333
http://dx.doi.org/10.1097/FTD.0000000000000483

Ejemplares similares